Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The many faces of tau.

Morris M, Maeda S, Vossel K, Mucke L.

Neuron. 2011 May 12;70(3):410-26. doi: 10.1016/j.neuron.2011.04.009. Review.

2.

Going new places using an old MAP: tau, microtubules and human neurodegenerative disease.

Garcia ML, Cleveland DW.

Curr Opin Cell Biol. 2001 Feb;13(1):41-8. Review.

PMID:
11163132
3.

Microtubule-associated protein tau in development, degeneration and protection of neurons.

Wang JZ, Liu F.

Prog Neurobiol. 2008 Jun;85(2):148-75. doi: 10.1016/j.pneurobio.2008.03.002. Epub 2008 Mar 22. Review.

PMID:
18448228
4.

Tau phosphorylation in neuronal cell function and dysfunction.

Johnson GV, Stoothoff WH.

J Cell Sci. 2004 Nov 15;117(Pt 24):5721-9. Review.

5.

Tau gene mutations: dissecting the pathogenesis of FTDP-17.

Ingram EM, Spillantini MG.

Trends Mol Med. 2002 Dec;8(12):555-62. Review.

PMID:
12470988
6.

Tau cleavage and tau aggregation in neurodegenerative disease.

Hanger DP, Wray S.

Biochem Soc Trans. 2010 Aug;38(4):1016-20. doi: 10.1042/BST0381016. Review.

PMID:
20658996
7.

Mutated tau binds less avidly to microtubules than wildtype tau in living cells.

Nagiec EW, Sampson KE, Abraham I.

J Neurosci Res. 2001 Feb 1;63(3):268-75.

PMID:
11170176
9.

Tau in neurodegenerative diseases: tau phosphorylation and assembly.

Avila J, Pérez M, Lim F, Gómez-Ramos A, Hernández F, Lucas JJ.

Neurotox Res. 2004;6(6):477-82. Review.

PMID:
15639780
10.

Intracellular and extracellular roles for tau in neurodegenerative disease.

Hanger DP, Lau DH, Phillips EC, Bondulich MK, Guo T, Woodward BW, Pooler AM, Noble W.

J Alzheimers Dis. 2014;40 Suppl 1:S37-45. doi: 10.3233/JAD-132054. Review.

PMID:
24595196
11.

Modeling Tauopathy in the fruit fly Drosophila melanogaster.

Khurana V.

J Alzheimers Dis. 2008 Dec;15(4):541-53. Review. Erratum in: J Alzheimers Dis. 2009 Mar;16(3):667-8.

PMID:
19096155
12.

The cytoskeleton in neurodegenerative diseases.

Cairns NJ, Lee VM, Trojanowski JQ.

J Pathol. 2004 Nov;204(4):438-49. Review.

13.

Tau as a therapeutic target in neurodegenerative disease.

Himmelstein DS, Ward SM, Lancia JK, Patterson KR, Binder LI.

Pharmacol Ther. 2012 Oct;136(1):8-22. doi: 10.1016/j.pharmthera.2012.07.001. Epub 2012 Jul 10. Review.

14.
15.

Tau-based treatment strategies in neurodegenerative diseases.

Schneider A, Mandelkow E.

Neurotherapeutics. 2008 Jul;5(3):443-57. doi: 10.1016/j.nurt.2008.05.006. Review.

PMID:
18625456
16.

Quantitative analysis of MAP-mediated regulation of microtubule dynamic instability in vitro focus on Tau.

Kiris E, Ventimiglia D, Feinstein SC.

Methods Cell Biol. 2010;95:481-503. doi: 10.1016/S0091-679X(10)95024-3. Review.

PMID:
20466149
17.
18.

Tau protein diffuses along the microtubule lattice.

Hinrichs MH, Jalal A, Brenner B, Mandelkow E, Kumar S, Scholz T.

J Biol Chem. 2012 Nov 9;287(46):38559-68. doi: 10.1074/jbc.M112.369785. Epub 2012 Sep 27.

19.

Tau protein mutations confirmed as neuron killers.

Vogel G.

Science. 1998 Jun 5;280(5369):1524-5. No abstract available.

PMID:
9644015
20.

Tau and axonopathy in neurodegenerative disorders.

Higuchi M, Lee VM, Trojanowski JQ.

Neuromolecular Med. 2002;2(2):131-50. Review.

PMID:
12428808
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk